Introduction A reliable diagnostic biomarker of iron status is required for severely anemic children living in malarious areas because presumptive treatment with iron may increase their infection risk if they are not iron deficient. Current biomarkers are limited because they are altered by host inflammation. In this study hepcidin concentrations were assessed in severely anemic children living in a highly malarious area of Malawi and evaluated against bone marrow iron in order to determine the usefulness of hepcidin as a point of care test. Methods 207 severely anemic children were assessed for levels of hepcidin, ferritin, serum transferrin receptor, erythropoietin, hematological indices, C-reactive protein, interleukin-6, malaria parasites and HIV infection. Deficiency of bone marrow iron stores was graded and erythroblast iron incorporation estimated. Interaction of covariates was assessed by structural-equation-modeling. Results and Conclusion Hepcidin was a poor predictor of bone marrow iron deficiency (sensitivity 66.7%; specificity 48.5%), and of iron incorporation (sensitivity 54.2%; specificity 61.8%), and therefore would have limitations as a point of care test in this category of children. As upregulation of hepcidin by inflammation and iron status was blunted by erythropoietin in this population, enhanced iron absorption through the low hepcidin values may increase infection risk. Current recommendations to treat all severely anemic children living in malarious areas with iron should therefore be reconsidered.
References
[1]
WHO (2005) Worldwide prevalence of anaemia 1993–2005. Available: www.who.int/entity/wormcontrol/documents？/joint_statements/en/ppc_unicef_finalrep？ort.pdf
[2]
Stoltzfus RJ (2001) Iron-deficiency anemia: reexamining the nature and magnitude of the public health problem. Summary: implications for research and programs. J Nutr 131: 697S–700S.
[3]
WHO (2001) Iron Deficiency Aneamia, Assessment, Prevention and Control, a guid for programme managers. Available: http://www.who.int/nutrition/publication？s/micronutrients/anaemia_iron_deficiency？/WHO_NHD_01.3/en/index.html
[4]
WHO (1998) WHO Guideline for the use of iron supplements to prevent and treat iron deficiency anemia. Available: http://www.who.int/nutrition/publication？s/micronutrients/anaemia_iron_deficiency？/1-57881-020-5/en/index.html
[5]
Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, et al. (2006) Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367: 133–143 S0140-6736(06)67962-2 [pii];10.1016/S0140-6736(06)67962-2 [doi].
[6]
WHO (2006) Conclusions and recommendations of the WHO Consultation on prevention and control of iron deficiency in infants and young children in malariaendemic areas. Available: http://www.who.int/nutrition/publication？s/micronutrients/FNBvol28N4supdec07.pdf
[7]
Calis JC, Phiri KS, Faragher EB, Brabin BJ, Bates I, et al. (2008) Severe anemia in Malawian children. N Engl J Med 358: 888–899 358/9/888 [pii];10.1056/NEJMoa072727 [doi].
[8]
Park CH, Valore EV, Waring AJ, Ganz T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276: 7806–7810 10.1074/jbc.M008922200 [doi];M008922200 [pii].
[9]
Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, et al. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98: 8780–8785 10.1073/pnas.151179498 [doi];151179498 [pii].
[10]
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, et al. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811–7819 10.1074/jbc.M008923200 [doi];M008923200 [pii].
[11]
Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D (2005) Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106: 1864–1866 2005-03-1159 [pii];10.1182/blood-2005-03-1159 [doi].
[12]
Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW (2011) Hepcidin in human iron disorders: diagnostic implications. Clin Chem 57: 1650–1669 clinchem.2009.140053 [pii];10.1373/clinchem.2009.140053 [doi].
[13]
Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, et al. (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101: 2461–2463 10.1182/blood-2002-10-3235 [doi];2002-10-3235 [pii].
[14]
Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24–38 S0092-8674(10)00718-X [pii];10.1016/j.cell.2010.06.028 [doi].
[15]
Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, et al. (2011) Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53: 1333–1341 10.1002/hep.24178 [doi].
[16]
Fleming RE, Ponka P (2012) Iron overload in human disease. N Engl J Med 366: 348–359 10.1056/NEJMra1004967 [doi].
[17]
Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, et al. (2012) Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood blood-2011-11-391219 [pii];10.1182/blood-2011-11-391219 [doi].
[18]
de Mast Q, van Dongen-Lases EC, Swinkels DW, Nieman AE, Roestenberg M, et al. (2009) Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol 145: 657–664 BJH7664 [pii];10.1111/j.1365-2141.2009.07664.x [doi].
[19]
de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, et al. (2009) Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis 199: 253–262 10.1086/595790 [doi].
[20]
Bain BJ (2001) Bone marrow Pathology. 3rd Edition.
[21]
Phiri KS, Calis JC, Siyasiya A, Bates I, Brabin B, et al. (2009) New cut-off values for ferritin and soluble transferrin receptor for the assessment of iron deficiency in children in a high infection pressure area. J Clin Pathol 62: 1103–1106 62/12/1103 [pii];10.1136/jcp.2009.066498 [doi].
[22]
Gale, Torrance J, Bothwell T (1963) The quantitative estimation of total iron stores in human bone marrow. J Clin Invest 42: 1076–1082 10.1172/JCI104793 [doi].
[23]
Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R (1993) Zinc protoporphyrin in anemia of chronic disorders. Blood 81: 1200–1204.
[24]
Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, et al. (2010) Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders. Clin Chem clinchem.2010.149187 [pii];10.1373/clinchem.2010.149187 [doi].
[25]
Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, et al. (2008) Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 3: e2706 10.1371/journal.pone.0002706 [doi].
[26]
Finch CA, Huebers H (1982) Perspectives in iron metabolism. N Engl J Med 306: 1520–1528 10.1056/NEJM198206243062504 [doi].
[27]
Hepcidinanalysis.com (2012) WCX-TOF MS reference values for serum Hepcidin-25 . Available: www.hepcidinanalysis.com/documents/Hepci？dinanalysis_ReferencevaluesWCX-TOFMS.pdf
[28]
WHO (2004) Assessing the iron status of populations, second edition of the World Health Organization. Available: http://www.who.int/nutrition/publication？s/micronutrients/anaemia_iron_deficiency？/9789241596107/en/index.html
[29]
Punnonen K, Irjala K, Rajamaki A (1997) Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89: 1052–1057.
[30]
Arbuckle JL (2007) Amos 6.0 User's guide SPSS.
[31]
Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, et al. (2011) Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 117: e218–e225 blood-2011-02-337907 [pii];10.1182/blood-2011-02-337907 [doi].
[32]
Vokurka M, Krijt J, Vavrova J, Necas E (2011) Hepcidin expression in the liver of mice with implanted tumour reacts to iron deficiency, inflammation and erythropoietin administration. Folia Biol (Praha) 57: 248–254 FB2011A0035 [pii].
[33]
Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, et al. (2008) An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One 3: e4030 10.1371/journal.pone.0004030 [doi].
[34]
Jaeggi T, Moretti D, Kvalsvig J, Holding PA, Tjalsma H, et al. (2013) Iron status and systemic inflammation, but not gut inflammation, strongly predict gender-specific concentrations of serum hepcidin in infants in rural Kenya. PLoS One 8: e57513 10.1371/journal.pone.0057513 [doi];PONE-D-12-35305 [pii].
[35]
Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, et al. (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114: 181–186 blood-2008-12-195503 [pii];10.1182/blood-2008-12-195503 [doi].
[36]
Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, et al. (2008) Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood 111: 5727–5733 blood-2007-08-106195 [pii];10.1182/blood-2007-08-106195 [doi].
[37]
Cercamondi CI, Egli IM, Ahouandjinou E, Dossa R, Zeder C, et al. (2010) Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women. Am J Clin Nutr 92: 1385–1392 ajcn.2010.30051 [pii];10.3945/ajcn.2010.30051 [doi].
[38]
Hughes DA, Stuart-Smith SE, Bain BJ (2004) How should stainable iron in bone marrow films be assessed? J Clin Pathol 57: 1038–1040 10.1136/jcp.2003.015834 [doi];57/10/1038 [pii].
[39]
Portugal S, Carret C, Recker M, Armitage AE, Goncalves LA, et al. (2011) Host-mediated regulation of superinfection in malaria. Nat Med 17: 732–737 nm.2368 [pii];10.1038/nm.2368 [doi].
[40]
Jonker FA, Calis JC, van Hensbroek MB, Phiri K, Geskus RB, et al. (2012) Iron status predicts malaria risk in Malawian preschool children. PLoS One 7: e42670 10.1371/journal.pone.0042670 [doi];PONE-D-12-08731 [pii].
